VECT — VectivBio Holding AG Income Statement
0.000.00%
Last trade - 00:00
HealthcareAdventurousMid Cap
- $1.06bn
- $846.20m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Depreciation and Amortization | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 24.3 | 57.3 | 86.7 | 80.5 |
Operating Profit | -24.3 | -57.3 | -86.7 | -80.5 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -23.5 | -59.9 | -86.9 | -93.6 |
Provision for Income Taxes | ||||
Net Income After Taxes | -23.5 | -59.9 | -87 | -93.7 |
Net Income Before Extraordinary Items | ||||
Net Income | -23.5 | -59.9 | -87 | -93.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -23.5 | -59.9 | -87 | -93.7 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.69 | -1.76 | -2.37 | -2.12 |
Dividends per Share |